Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma-Reference-Cited by-同舟云学术

Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma

Published:2015-05 Issue:5 Volume:10 Page:738-746
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Lohinai Zoltan,Hoda Mir Alireza,Fabian Katalin,Ostoros Gyula,Raso Erzsebet,Barbai Tamas,Timar Jozsef,Kovalszky Ilona,Cserepes Mihaly,Rozsas Anita,Laszlo Viktoria,Grusch Michael,Berger Walter,Klepetko Walter,Moldvay Judit,Dome Balazs,Hegedus Balazs

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference43 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. A novel classification of lung cancer into molecular subtypes;West;PLoS One,2012

3. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

4. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain;Pao;PLoS Med,2005

5. EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity;Vikis;Cancer Res,2007

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological and prognostic implications of EGFR mutations subtypes in Moroccan non-small cell lung cancer patients: A first report;PLOS ONE;2024-06-05

2. Clinicopathological characterization of next-generation sequencing detected mutations in lung cancers—a single-center experience;Translational Lung Cancer Research;2024-04

3. Clinical features and outcomes of unresectable locally advanced non-small cell lung cancer with uncommon EGFR Mutations: A retrospective multi-center Chinese study;2024-03-25

4. Hope and Challenges: Immunotherapy in EGFR-Mutant NSCLC Patients;Biomedicines;2023-10-28

5. Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer;Journal of Personalized Medicine;2023-01-17